-transparent.png){kind=logo}
Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and is associated with three human malignancies. Acyclovir [9-(2-hydroxyethoxymethyl)guanine], the first clinically useful drug effective against replication of EBV, is without effect against latent or persistent EBV infection. Three nucleoside analogs, E-5-(2-bromovinyl)-2'-deoxyuridine, 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine, and 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil are potent inhibitors of EBV replication in vitro. Moreover, in contrast to the reversibility of viral inhibition by Acyclovir, these three drugs have prolonged effects in suppressing viral replication even after the drugs are removed from persistently infected cell cultures.
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
September 1980,
Proceedings of the National Academy of Sciences of the United States of America,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
May 1996,
Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
January 2009,
Antiviral therapy,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
October 1981,
Virology,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
May 1976,
Virology,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
January 1989,
Current topics in microbiology and immunology,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
January 1986,
Journal of virology,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
January 2019,
Journal of virology,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
May 1984,
The New England journal of medicine,
J C Lin, and
M C Smith, and
Y C Cheng, and
J S Pagano
January 2012,
Journal of innate immunity,
